We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$99.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$80.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$77.7M
4
EA icon
Electronic Arts
EA
+$61.9M
5
DHR icon
Danaher
DHR
+$60.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCT icon
401
Arcturus Therapeutics
ARCT
$177M
$349K 0.01%
+8,442
New +$503K
FRLN
402
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$319K 0.01%
1,729
– –
CAHCU
403
DELISTED
CA Healthcare Acquisition Corp. Unit
CAHCU
$281K 0.01%
+28,412
New +$289K
ARYD
404
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$267K 0.01%
+25,522
New +$276K
ABUS icon
405
Arbutus Biopharma
ABUS
$913M
$261K 0.01%
+78,339
New +$302K
CFVIU
406
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
$248K 0.01%
+25,000
New +$253K
CHMA
407
DELISTED
Chiasma, Inc. Common Stock
CHMA
$218K ﹤0.01%
69,761
-1,146,751
-94% -$4.4M
WPCA.U
408
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$202K ﹤0.01%
+20,000
New +$202K
AUS.U
409
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$145K ﹤0.01%
+14,394
New +$146K
MOTV.WS
410
DELISTED
Motive Capital Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an ex
MOTV.WS
$115K ﹤0.01%
+130,255
New +$209K
DLCA
411
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$105K ﹤0.01%
+10,754
New +$105K
SLCRW
412
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$85K ﹤0.01%
+167,354
New +$104K
LMACW
413
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$75K ﹤0.01%
+24,800
New +$97K
SDSTW
414
Stardust Power Inc Warrant
SDSTW
$6.41M
$61K ﹤0.01%
+58,333
New +$68.6K
EFTRW
415
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$57K ﹤0.01%
+93,922
New +$90.6K
FVT.WS
416
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$52K ﹤0.01%
+49,938
New +$68.2K
SHACW
417
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$44K ﹤0.01%
+75,000
New +$46K
KLAQW
418
DELISTED
KL Acquisition Corp Warrant
KLAQW
$41K ﹤0.01%
+63,052
New +$53.9K
TZPSW
419
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$40K ﹤0.01%
+58,333
New +$51.3K
JCICW
420
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$38K ﹤0.01%
+71,418
New +$49.1K
POWRW
421
DELISTED
Powered Brands Warrants
POWRW
$38K ﹤0.01%
+50,000
New +$53.4K
FINMW
422
DELISTED
Marlin Technology Corporation Warrant
FINMW
$34K ﹤0.01%
+47,160
New +$41.4K
GSAQW
423
DELISTED
Global Synergy Acquisition Corp. Warrant
GSAQW
$32K ﹤0.01%
+62,500
New +$47K
FCAX.WS
424
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$28K ﹤0.01%
+28,370
New +$34.6K
HCICW
425
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$27K ﹤0.01%
+24,684
New +$35.8K
15 16
17
18 19

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.